United StatesHouse Bill 3821HR 3821
ADINA Act
Health
3 pages
- house
- senate
- president
Last progress June 6, 2025 (6 months ago)
Introduced on June 6, 2025 by Kelly Morrison
House Votes
Pending Committee
June 6, 2025 (6 months ago)Referred to the House Committee on Energy and Commerce.
Senate Votes
Vote Data Not Available
Presidential Signature
Signature Data Not Available
AI Summary
This bill would require drug labels to clearly say if a human-use medicine contains any ingredient that is, or is made from, a major food allergen or a gluten grain. Labels would also need to name each such ingredient and, if it involves gluten, state which grain it comes from (like wheat, barley, rye, or their hybrids).
Companies would have up to two years after the law takes effect to update labels, unless the Health and Human Services Secretary sets an earlier date.
- Who is affected: People who take medicines and have food allergies or need to avoid gluten; drug makers and distributors that label medicines.
- What changes: Drug labels must disclose any ingredients that are or come from major food allergens or gluten grains, and identify the specific grain when it’s gluten-related.
- When: No later than two years after the law is enacted, unless an earlier date is set by the Secretary of Health and Human Services.
Text Versions
Text as it was Introduced in House
ViewJune 6, 2025•3 pages
Amendments
No Amendments